Publications by authors named "Satya S Pathi"

Claim this Profile
A
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology.
Katrin P Guillen, Maihi Fujita, Andrew J Butterfield, Sandra D Scherer, Matthew H Bailey, Satya S Pathi

Nat Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cancer-Selective Zinc Ionophore Inspired by the Natural Product Naamidine A.
Rachel M Vaden, Katrin P Guillen, Justin M Salvant, Celine B Santiago, Joseph B Gibbons, Satya S Pathi

ACS Chem Biol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
Balabhadrapatruni V S K Chakravarthi, Darshan S Chandrashekar, Sumit Agarwal, Sai Akshaya Hodigere Balasubramanya, Satya S Pathi

Mol Cancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancer.
Balabhadrapatruni V S K Chakravarthi, Moloy T Goswami, Satya S Pathi, Matthew Dodson, Darshan S Chandrashekar

Prostate· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate Cancer.
Balabhadrapatruni V S K Chakravarthi, Moloy T Goswami, Satya S Pathi, Matthew Dodson, Darshan S Chandrashekar

Prostate· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.
Xi Li, Satya S Pathi, Stephen Safe

BMC Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.
Moloy T Goswami, Guoan Chen, Balabhadrapatruni V S K Chakravarthi, Satya S Pathi, Sharath K Anand

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.
Balabhadrapatruni V S K Chakravarthi, Satya Sreehari Pathi, Moloy T Goswami, Marcin Cieślik, Heng Zheng

Oncotarget· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
Kyounghyun Kim, Gayathri Chadalapaka, Satya S Pathi, Un-Ho Jin, Ju-Seog Lee

Mol Cancer Ther· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
zRICH, a protein induced during optic nerve regeneration in zebrafish, promotes neuritogenesis and interacts with tubulin.
Satya S Pathi, Soumia Jose, Suman Govindaraju, Juan A Conde, Hannah E Romo

Brain Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.
Satya S Pathi, Ping Lei, Sandeep Sreevalsan, Gayathri Chadalapaka, Indira Jutooru

Nutr Cancer· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
Satya S Pathi, Indira Jutooru, Gayathri Chadalapaka, Sandeep Sreevalsan, S Anand

Mol Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis